Relx Plc (NYSE:RELX) Shares Bought by Northwest & Ethical Investments L.P.

Northwest & Ethical Investments L.P. grew its position in Relx Plc (NYSE:RELX - Free Report) by 5.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 210,600 shares of the technology company's stock after buying an additional 11,139 shares during the period. Northwest & Ethical Investments L.P.'s holdings in Relx were worth $9,565,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of RELX. FMR LLC raised its stake in Relx by 8.3% in the third quarter. FMR LLC now owns 7,148,837 shares of the technology company's stock valued at $339,284,000 after buying an additional 548,423 shares during the last quarter. Natixis Advisors LLC increased its holdings in shares of Relx by 2.8% during the fourth quarter. Natixis Advisors LLC now owns 1,202,592 shares of the technology company's stock valued at $54,622,000 after acquiring an additional 32,739 shares in the last quarter. Captrust Financial Advisors raised its position in shares of Relx by 3.4% in the 3rd quarter. Captrust Financial Advisors now owns 1,103,797 shares of the technology company's stock valued at $52,386,000 after purchasing an additional 35,807 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Relx in the 4th quarter worth approximately $44,516,000. Finally, JPMorgan Chase & Co. grew its position in Relx by 14.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company's stock worth $39,225,000 after purchasing an additional 104,999 shares during the last quarter. 15.02% of the stock is currently owned by institutional investors.

Relx Stock Performance

NYSE:RELX traded up $0.58 during midday trading on Tuesday, hitting $50.39. The company's stock had a trading volume of 344,200 shares, compared to its average volume of 729,017. Relx Plc has a fifty-two week low of $40.25 and a fifty-two week high of $51.99. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The firm has a market cap of $93.53 billion, a P/E ratio of 27.09, a P/E/G ratio of 2.73 and a beta of 0.90. The firm's 50 day moving average is $49.26 and its 200-day moving average is $47.73.

Remove Ads

Relx Increases Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be issued a dividend of $0.5586 per share. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. This is a boost from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio (DPR) is 59.68%.

Analysts Set New Price Targets

RELX has been the subject of a number of research analyst reports. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Redburn Atlantic began coverage on Relx in a research note on Wednesday, January 8th. They issued a "buy" rating for the company. Finally, StockNews.com cut Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.